Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Prospective and End User Evaluation of an AI-based Clinical Decision Support System for Individualized Antimicrobial Stewardship
0
Zitationen
6
Autoren
2025
Jahr
Abstract
Discussion: Dragonfly's LAMP-based colorimetric approach offers a sample-to-result diagnostic solution for infectious diseases.Its portability and rapid testing (under 40 minutes) without the need for laboratory infrastructure or cold chain requirements make it a valuable tool for on-site diagnostics.The Dragonfly skin test panel, targeting OPXV, mpox, HSV-1, HSV-2, and VZV, supports the differential diagnosis of skin lesions and aids in screening and surveillance of suspected mpox cases.While LAMP-based solutions for mpox detection have emerged, none provide a fast, lowresource sample-to-result solution like Dragonfly. Conclusion:The recent mpox outbreak underscores the critical need for accessible, rapid, point-of-care diagnostics for screening and surveillance.Dragonfly's sample-to-result solution for skin lesions addresses this need, offering accessible diagnostics in the field and aiding in outbreak control effort s.
Ähnliche Arbeiten
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
2000 · 16.888 Zit.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
2022 · 14.592 Zit.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 · 13.605 Zit.
Performance standards for antimicrobial susceptibility testing
2001 · 9.766 Zit.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
2017 · 5.928 Zit.